An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis

ClinicalTrials.gov ID: NCT02808780

Public ClinicalTrials.gov record NCT02808780. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 19, 2026, 9:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to describe the long-term safety risks in adult participants with moderate-to-severe ulcerative colitis who are treated with Simponi.

Study identification

NCT ID: NCT02808780
Recruitment status: Active, not recruiting
Study type: Observational
Phase: Not listed
Lead sponsor: Janssen Biotech, Inc.; Industry
Enrollment: 535 participants

Conditions and interventions

Conditions

Ulcerative Colitis

Interventions

Not listed

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 16, 2016 (Actual)
Primary completion: Dec 10, 2026 (Estimated)
Completion: Mar 11, 2027 (Estimated)
Last update posted: Sep 25, 2026

2016 – 2027

United States locations

U.S. sites: 16
U.S. states: 8
U.S. cities: 16

Facility	City	State	ZIP	Site status
Not listed	Murrieta	California	—	—
Not listed	Rialto	California	—	—
Not listed	Ventura	California	—	—
Not listed	Coral Gables	Florida	—	—
Not listed	Fort Myers	Florida	—	—
Not listed	Lake Worth	Florida	—	—
Not listed	Lauderdale Lakes	Florida	—	—
Not listed	Miami	Florida	—	—
Not listed	Tampa	Florida	—	—
Not listed	Suwanee	Georgia	—	—
Not listed	Chicago	Illinois	—	—
Not listed	Sylvania	Ohio	—	—
Not listed	Pittsburgh	Pennsylvania	—	—
Not listed	Houston	Texas	—	—
Not listed	San Antonio	Texas	—	—
Not listed	Lansdowne Town Center	Virginia	—	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 47 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02808780, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 25, 2026 · Synced Oct 19, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02808780 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →